PL2555787T3 - Formulacja kurkuminy o zwiększonej biodostępności kurkuminy i sposób jej wytwarzania i traktowania - Google Patents

Formulacja kurkuminy o zwiększonej biodostępności kurkuminy i sposób jej wytwarzania i traktowania

Info

Publication number
PL2555787T3
PL2555787T3 PL11765166T PL11765166T PL2555787T3 PL 2555787 T3 PL2555787 T3 PL 2555787T3 PL 11765166 T PL11765166 T PL 11765166T PL 11765166 T PL11765166 T PL 11765166T PL 2555787 T3 PL2555787 T3 PL 2555787T3
Authority
PL
Poland
Prior art keywords
curcumin
formulation
preparation
treatment
enhanced bioavailability
Prior art date
Application number
PL11765166T
Other languages
English (en)
Inventor
Benny Antony
Original Assignee
Benny Antony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benny Antony filed Critical Benny Antony
Publication of PL2555787T3 publication Critical patent/PL2555787T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL11765166T 2010-04-05 2011-04-04 Formulacja kurkuminy o zwiększonej biodostępności kurkuminy i sposób jej wytwarzania i traktowania PL2555787T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN950CH2010 2010-04-05
PCT/IN2011/000232 WO2011125070A2 (en) 2010-04-05 2011-04-04 Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
EP11765166.1A EP2555787B1 (en) 2010-04-05 2011-04-04 Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof

Publications (1)

Publication Number Publication Date
PL2555787T3 true PL2555787T3 (pl) 2018-04-30

Family

ID=44763344

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11765166T PL2555787T3 (pl) 2010-04-05 2011-04-04 Formulacja kurkuminy o zwiększonej biodostępności kurkuminy i sposób jej wytwarzania i traktowania

Country Status (6)

Country Link
EP (2) EP3290045A1 (pl)
DK (1) DK2555787T3 (pl)
ES (1) ES2657364T3 (pl)
NO (1) NO2555787T3 (pl)
PL (1) PL2555787T3 (pl)
WO (1) WO2011125070A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2013CH00226A (pl) * 2013-01-17 2015-08-07 Benny Antony
WO2014068597A2 (en) * 2012-11-03 2014-05-08 Benny Antony Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
GB201111319D0 (en) * 2011-07-04 2011-08-17 Univ Leuven Kath Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa
CN102697887A (zh) * 2012-06-26 2012-10-03 南京辰逸生物科技有限公司 一种治疗类风湿性关节炎的中药组合物
JP2017506224A (ja) 2014-02-05 2017-03-02 ライラ ニュートラシューティカルズ 炎症性疾患の予防、治療又は制御のための相乗的食品補助組成物
BE1024442B1 (nl) * 2016-07-27 2018-02-28 Nutrisan Nv Samenstelling en gebruik van een voedingssupplement
JP7547324B2 (ja) 2018-09-26 2024-09-09 ニュートリベンティア リミテッド クルクミノイドコンポジット
US12514829B2 (en) 2018-09-26 2026-01-06 Nutriventia Private Limited Curcuminoid composites
CN111991376B (zh) * 2020-08-26 2022-12-16 广东工业大学 芳姜黄酮在制备防治溃疡性结肠炎及调节肠道菌群的产品中的应用
WO2022115063A1 (en) * 2020-11-30 2022-06-02 Kavak Çi̇ftci̇ Gida İçecek Organi̇k Gübre Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ A composition of a food supplement and production method thereof
US12251415B1 (en) 2024-01-18 2025-03-18 Arjuna Natural Private Limited Curcuminoid composition of curcumin-keto, method of preparation and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1274300C (zh) * 2003-12-11 2006-09-13 中国科学院生物物理研究所 用于改善姜黄素溶出度和生物利用度的药物组合物及其制备方法
CN1568944A (zh) * 2004-04-28 2005-01-26 广西南宁邕江药业有限公司 姜黄素及其衍生物用于制备治疗抑郁症药物的应用
ES2709653T3 (es) * 2005-05-30 2019-04-17 Benny Antony Método para mejorar la biodisponibilidad de la curcumina
US7883728B2 (en) * 2005-05-30 2011-02-08 Arjuna Natural Extracts, Ltd. Composition to enhance the bioavailability of curcumin

Also Published As

Publication number Publication date
WO2011125070A3 (en) 2011-12-08
WO2011125070A2 (en) 2011-10-13
DK2555787T3 (da) 2018-01-29
EP3290045A1 (en) 2018-03-07
EP2555787B1 (en) 2017-11-08
EP2555787A4 (en) 2013-10-23
EP2555787A2 (en) 2013-02-13
ES2657364T3 (es) 2018-03-05
NO2555787T3 (pl) 2018-04-07

Similar Documents

Publication Publication Date Title
PL2555787T3 (pl) Formulacja kurkuminy o zwiększonej biodostępności kurkuminy i sposób jej wytwarzania i traktowania
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
EP2564847A4 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVING PRASUGREL SOLUBILITY AND PREPARATION METHOD THEREOF
ZA201208265B (en) Pharmaceutical compositions and methods of making same
EP2657188A4 (en) FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME
ZA201300002B (en) Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor
EP2521553A4 (en) METHODS AND COMPOSITIONS FOR THE DEVELOPMENT OF TARGETED MEDICAMENTS
GB201104473D0 (en) Improved pharmaceutical compositions and methods of delivery
GB2505860B (en) Aripiprazole medicament formulation and preparation method therefor
IL221043A0 (en) Modified release formulation and methods of use
EP2574172A4 (en) MATERIALS AND METHOD FOR TREATING INFLAMMATION
AP2012006514A0 (en) Polymorphic forms ST-246 and methods of preparation
ZA201301936B (en) Methods and compositions for treatment of diabetes and dyslipidemia
IL231505B (en) Pharmaceutical preparation and method for its production
PL2544548T3 (pl) Sposób wytwarzania stabilnego i jednorodnego preparatu owocowego
ZA201202892B (en) Ophthalmic formulation and method of manufacture thereof
EP2917188B8 (en) Solid dispersions of insoluble drug and preparation method thereof
EP2552915A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF HIV
EP2575891A4 (en) FORMULATIONS PRESERVING BIOACTIVITY AND METHODS FOR THEIR PREPARATION
SG11201401454XA (en) Derivative of butylphthalide and preparation method and use thereof
EP2610257A4 (en) DIIMIDED DERIVATIVE OF BERBAMINE, MANUFACTURING METHOD AND ITS USE
SI2654723T1 (sl) Trdne farmacevtske dozirna oblike, ki obsegajo tadalafil in metode za njihovo pripravo
EP2617293A4 (en) INGREDIENT MASKING AMERTUME AND METHOD OF MASKING AMERTUME
EP2640468A4 (en) ADMINISTRATIVE AND TREATMENT PROCEDURES
GB201002278D0 (en) composition and method of preparation